In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mexico puts US$46m into HIV/STI centres plan

This article was originally published in Clinica

Executive Summary

Mexico has announced plans to invest M$500m (US$46.4m) in 51 ambulatory HIV and sexually-transmitted infection (STI) care and prevention centres. The aim of the CAPASITS (Centro Ambulatorio de Prevencion y Atencion en VIH/SIDA e Infecciones de Transmision Sexual) network is to provide widespread access to HIV/STI services, as well as free treatment for the around 20,000 (of around 180,000) HIV patients who are not insured under Mexico's IMSS, ISSSTE or other social insurance programmes.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT049187

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel